Connor, Clark & Lunn Investment Management Ltd. Regeneron Pharmaceuticals, Inc. Transaction History

Connor, Clark & Lunn Investment Management Ltd.

$21.8 Billion
Q1 2024

A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 2,001 shares of REGN stock, worth $2.1 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

2,001

Previous 2,186 8.46%

Holding current value

$2.1 Million

Previous $1.92 Million 0.31%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$902.69 - $993.35 $166,997 - $183,769	-185 Reduced 8.46%	2,001 $1.93 Million
Q4 2023 Feb 09, 2024	SELL	$775.18 - $881.7 $372,086 - $423,216	-480 Reduced 18.0%	2,186 $1.92 Million
Q3 2023 Nov 13, 2023	SELL	$692.45 - $844.37 $9.89 Million - $12.1 Million	-14,287 Reduced 84.27%	2,666 $2.19 Million
Q2 2023 Aug 10, 2023	SELL	$700.03 - $830.35 $8.98 Million - $10.7 Million	-12,834 Reduced 43.09%	16,953 $12.2 Million
Q1 2023 May 09, 2023	BUY	$680.49 - $826.97 $7.88 Million - $9.58 Million	11,581 Added 63.61%	29,787 $24.5 Million

Q4 2022 Feb 10, 2023	BUY	$705.89 - $766.39 $9.86 Million - $10.7 Million	13,972 Added 330.0%	18,206 $13.1 Million
Q3 2022 Nov 10, 2022	BUY	$573.97 - $724.32 $634,810 - $801,097	1,106 Added 35.36%	4,234 $2.92 Million
Q2 2022 Aug 05, 2022	SELL	$548.35 - $738.84 $2.85 Million - $3.84 Million	-5,204 Reduced 62.46%	3,128 $1.85 Million
Q1 2022 May 12, 2022	SELL	$595.12 - $698.43 $5.6 Million - $6.57 Million	-9,407 Reduced 53.03%	8,332 $5.82 Million
Q4 2021 Feb 10, 2022	BUY	$543.48 - $670.97 $3.2 Million - $3.94 Million	5,879 Added 49.57%	17,739 $11.2 Million
Q3 2021 Nov 12, 2021	SELL	$574.03 - $680.96 $7.53 Million - $8.94 Million	-13,124 Reduced 52.53%	11,860 $7.18 Million
Q2 2021 Aug 12, 2021	SELL	$472.8 - $558.54 $475,636 - $561,891	-1,006 Reduced 3.87%	24,984 $14 Million
Q1 2021 May 13, 2021	BUY	$446.73 - $548.2 $7.9 Million - $9.7 Million	17,687 Added 213.02%	25,990 $12.3 Million
Q4 2020 Feb 16, 2021	BUY	$478.3 - $607.98 $547,653 - $696,137	1,145 Added 16.0%	8,303 $4.01 Million
Q3 2020 Nov 12, 2020	BUY	$544.75 - $658.21 $1.26 Million - $1.52 Million	2,310 Added 47.65%	7,158 $4.01 Million
Q2 2020 Aug 13, 2020	BUY	$493.32 - $643.92 $452,867 - $591,118	918 Added 23.36%	4,848 $3.02 Million
Q1 2020 May 13, 2020	SELL	$336.18 - $494.43 $5.4 Million - $7.95 Million	-16,070 Reduced 80.35%	3,930 $1.92 Million
Q4 2019 Feb 12, 2020	BUY	$274.13 - $376.51 $4.02 Million - $5.53 Million	14,675 Added 275.59%	20,000 $7.51 Million
Q3 2019 Nov 13, 2019	SELL	$273.46 - $318.39 $3.34 Million - $3.89 Million	-12,225 Reduced 69.66%	5,325 $1.48 Million
Q2 2019 Aug 07, 2019	BUY	$299.6 - $414.82 $3.94 Million - $5.45 Million	13,150 Added 298.86%	17,550 $5.49 Million
Q1 2019 May 08, 2019	BUY	$372.08 - $439.57 $586,026 - $692,322	1,575 Added 55.75%	4,400 $1.81 Million
Q4 2018 Feb 12, 2019	SELL	$335.82 - $403.04 $545,707 - $654,940	-1,625 Reduced 36.52%	2,825 $1.06 Million
Q3 2018 Nov 13, 2018	BUY	$351.14 - $408.51 $219,462 - $255,318	625 Added 16.34%	4,450 $1.8 Million
Q2 2018 Aug 02, 2018	SELL	$284.6 - $344.99 $113,840 - $137,996	-400 Reduced 9.47%	3,825 $1.32 Million
Q1 2018 May 14, 2018	SELL	$315.82 - $393.78 $228,969 - $285,490	-725 Reduced 14.65%	4,225 $1.46 Million
Q4 2017 Feb 09, 2018	BUY	$358.63 - $469.95 $8,965 - $11,748	25 Added 0.51%	4,950 $1.86 Million
Q3 2017 Nov 14, 2017	BUY	$431.38 - $504.0 $269,612 - $315,000	625 Added 14.53%	4,925 $2.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	4,300	4,300 $2.11 Million

Others Institutions Holding REGN

# of Institutions

1,424

Shares Held

82.1M

Call Options Held

835K

Put Options Held

1.46M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $113B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.

Account

Connor, Clark & Lunn Investment Management Ltd. Regeneron Pharmaceuticals, Inc. Transaction History